Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.36 (
hyaluronidase
)
4,606
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Prepuberal (P) gilts were induced to ovulate with pregnant mare serum gonadotropin followed 72 h later by human
chorionic gonadotropin
(hCG). Three P gilts and three mature (M) gilts each were ovariectomized on d 10, 14, 18, 22 and 26 (d 0 = day of hCG for P gilts and onset of estrus for M gilts). Gilts ovariectomized on d 14, 18, 22 and 26 were hysterectomized on d 6 to ensure maintenance of the corpora lutea (CL). Two to five grams of minced luteal tissue were dispersed using collagenase and
hyaluronidase
in HEPES buffered salt solution supplemented with glucose and bovine serum albumin. Dispersed cells were rinsed in Dulbecco's Modified Eagle Medium (DMEM), counted (ratio of large to total number of luteal cells determined) and then incubated for 1 h in DMEM. With aliquots standardized to 2.5 X 10(4) viable, large cells (greater than 25 micron diameter) were incubated in 1 ml DMEM for 2 h in the presence of either 10, 50, 100 or 1,000 ng luteinizing hormone (LH); .1, 1, 10 or 100 ng hCG; 10, 100 or 1,000 ng norepinephrine (NE) or either .75, or 1.5 mM dibutyrl cyclic adenosine monophosphate (dbcAMP). Progesterone (P4) in the medium was quantified by radioimmunoassay. Basal P4 production (no P4 stimulator added to the medium) on d 10, 14, 18, 22 and 26 for P gilts was 246 +/- 9, 66 +/- 4, 64 +/- 6, 41 +/- 3 and 69 +/- 6 ng/ml medium, respectively, and for M gilts was 281 +/- 12, 128 +/- 8, 53 +/- 4, 82 +/- 6, 101 +/- 5 ng/ml medium, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Comparison of induced corpora lutea from prepuberal gilts and spontaneous corpora lutea from mature gilts: in vitro progesterone production. 303 Sep 95
A high incidence of parthenogenetic activation was observed when postovulatory aged mouse oocytes were exposed briefly to
hyaluronidase
in culture medium at 18-26 h after the human
chorionic gonadotropin
injection for inducing superovulation. The majority of the activated oocytes extruded a second polar body and developed a single haploid pronucleus. Cytogenetic analysis of this class of parthenogenone at metaphase of the first-cleavage mitosis has clearly demonstrated that the completion of the second meiotic division in activated aged oocytes is not associated with a significant increase in the incidence of chromosome segregation errors. The increasing postovulatory age of oocytes prior to activation was observed to significantly decrease the capacity of activated oocytes to extrude the second polar body.
...
PMID:Influence of postovulatory aging on chromosome segregation during the second meiotic division in mouse oocytes: a parthenogenetic analysis. 318 1
One hundred seventeen oocyte-cumulus-corona cell complexes (CCCs) were obtained from 15 women undergoing in vitro fertilization after human menopausal gonadotropin/human
chorionic gonadotropin
follicular stimulation. In each woman, five oocyte-CCCs were left intact, and the remaining one to five oocytes were freed of their CCCs by
hyaluronidase
(300 IU/ml) dispersal treatment. Dispersal time for individual CCCs correlated well with their degree of mucification and was significantly shorter in 20 mature CCCs as compared with 24 intermediate CCCs (1.20 +/- 0.05 versus 2.35 +/- 0.13 minutes, respectively; P less than 0.001). Oocyte maturation at collection and after 8 hours of in vitro incubation was not related to the CCC type present at harvest. Maturation of oocytes progressed regardless of CCC type; so that after 8 hours of preincubation, 73% of the oocytes attained a polar body while 20% were still at the germinal vesicle breakdown stage and 7% at the germinal vesicle stage. Overall, the 44 denuded oocytes and 72 intact oocyte-CCCs were comparable in rate of fertilization (64% versus 68%) and subsequent cleavage (75% versus 82% of all fertilized oocytes). It is concluded that in human menopausal gonadotropin-stimulated cycles, asynchrony between individual CCC mucification and oocyte maturation may occur, and that the absence of CCC does not seem to affect in vitro fertilization and cleavage rates.
...
PMID:Asynchrony between human cumulus-corona cell complex and oocyte maturation after human menopausal gonadotropin treatment for in vitro fertilization. 643 86
This article reviews new advances in biochemistry, biotechnology, and immunology relevant to antifertility vaccine development and evaluates the current status and future prospects of contraceptive vaccines and other immunologic approaches to fertility regulation. Contraceptive vaccine candidates include human
chorionic gonadotropin
, human luteinizing hormone and luteinizing hormone releasing hormone, and reproductive steroid hormones. Sperm enzymes are attractive for a contraceptive vaccine; among the sperm antigens studied are antibodies to
hyaluronidase
, acrosin, and lactate dehydrogenase-C4. Several laboratories have developed monoclonal antibodies to a variety of sperm antigens and are using them to identify and characterize new sperm proteins and their roles in fertility. Considerable progress has been made toward biochemical characterization of unique glycoproteins constituting the zona pellucida. Zona pellucida antigens are good candidates because antizona antibodies may block both fertilization and implantation, and low amounts of antibody would be sufficient because of the small number of mature eggs with zona present at any time. Studies are underway to identify human embryonic antigens through examination of the protein profile of human teratocarcinoma cell lines at various stages of differentiation and through analysis of antibodies in human pregnancy and infertility sera. Placental and extraembryonic membranes produce several tissue-specific antigens that have been considered for antifertility vaccines, but concern that they could produce late or incomplete abortion has prevented their serioud consideration. Because of possibly serious systemic side effects, presence of the blood-testis barrier, and large number of sperm produced daily, it is unlikely that sperm vaccines can be safely administered to men. Nautural protective mechanisms will probably render some immunocontraceptive approaches ineffective. The possibility of serious pathogenic side effects of contraceptive vaccines demands vaccines demands a cautious approach to their development.
...
PMID:A new look at antifertility vaccines. 657 34
Immunointerruption of pregnancy consists of preventing pregnancy or terminating it at an early stage through antibodies. The antibodies may be obtained after administration of vaccine to induce their formation through active immunization, or by direct injection through passive immunization. Antigens that could potentially be used are found in sperm, the zona pellucida, and reproductive hormones, especially the chorionic gonadotropins. The sperm antigens are basically enzymes such as
hyaluronidase
and accrosine. 3 glucoproteins have been identified in the zona pellucida of mice and pigs. In vitro studies have shown that fertilization can be prevented if eggs are exposed to antizona-pellucida antibodies along with sperm. Active immunization could give longer term results, but ovarian function could also be affected if the antigens weren't purified. Much research has been devoted to identifying human embryonic antigens through analysis of the proteins of the cells of embryonic teratocarcinoma. Among placental antigens, the glucoprotein SP1 synthesized by the trophoblast is under study. Anti-SP1 antibodies appear to cause abortion in monkeys, but knowledge of these antigens is still fragmentary. Various reproductive hormones have been studied, but too many undesirable effects could result from the use of luteinizing hormone, luteinizing hormone releasing hormone, follicle stimulation hormone, or steroids. Human
chorionic gonadotropin
(hCG), however, is more promising. It is a glucoprotein formed of alpha and beta subunits, both of which are needed for hCG to interact with its receptor. The alpha subunit has the same sequence as that of other hormones of the same species, but the beta subunit is specific to each hormone. Studies are underway to determine the site of amino acids and peptide sequences capable of inducing an anti-hCG response which would inactivate the biological activity of hCG. Different teams have used synthetic peptides analogous to sequences of beta-hCG or fragments obtained by enzymatic cleavage of natural hCG to block pregnancy in rats and baboons. The presence of antibodies can block pregnancy without disturbing ovulation or modifying menstrual regularity. No toxic or secondary effect has been observed in animals. A multicenter phase 1 test using beta-hCG coupled with tetanus antitoxin caused almost all the women participating to develop antibeta-hCG and antitetanus anatoxin antibodies, but titres of antibodies varied greatly between different women, required 5-6 months to develop, and declined rapidly thereafter. Several pregnancies were observed, especially in women with low titres of antibodies. The approach of passive immunization through direct injection of antibodies has met with numerous obstacles, including lack of success in producing human monoclonal antibodies. Although a 2nd generation of vaccines in under study, the potential role of immunointerruption of pregnancy in fertility regulation remains to be clarified.
...
PMID:[Regulation of fertility by anti-hCG vaccines]. 1228 Dec 42
During ovarian folliculogenesis, the vast majority of follicles will undergo atresia by apoptosis, allowing a few dominant follicles to mature. Mammalian hyaluronidases comprise a family of six to seven enzymes sharing the same catalytic domain responsible for hyaluronan hydrolysis. Interestingly, some of these enzymes have been shown to induce apoptosis. In the ovary, expression of three hyaluronidases (Hyal-1, Hyal-2, and Hyal-3) has been documented. However, their precise cellular localization and role in ovarian regulation have not yet been defined. We herein investigated the possible involvement of these enzymes in ovarian atresia. First, we established a mouse model for ovarian atresia (gonadotropin withdrawal by anti-equine
chorionic gonadotropin
treatment) and showed that the mRNA levels of Hyal-1, Hyal-2, and Hyal-3 were significantly increased in apoptotic granulosa cells as well as in atretic follicles. Second, using ovaries of normally cycling mice, we demonstrated the correlation of Hyal-1 mRNA and protein expression with cleavage of caspase-3. In addition, we showed that expression of all three hyaluronidases induced apoptosis in transfected granulosa cells. Significantly, the induction of apoptosis by hyaluronidases was independent of catalytic activity, because enzymatically inactive Hyal-1 mutant (D157A/E159A) was as efficient as the wild-type enzyme in apoptosis induction. The activation of the extrinsic apoptotic signaling pathway was involved in this induction, because increased levels of cleaved caspase-8, caspase-3, and poly-ADP-ribose polymerase (PARP) were observed upon
hyaluronidase
ectopic expression. Our present findings provide a better understanding of the role of hyaluronidases in ovarian functions, showing for the first time their involvement in follicular atresia.
...
PMID:Mammalian hyaluronidase induces ovarian granulosa cell apoptosis and is involved in follicular atresia. 1865 6
Complex and hybrid N-glycans generated by N-acetylglucosaminyltransferase I (GlcNAcT-I), encoded by Mgat1, affect the functions of glycoproteins. We have previously shown that females with oocyte-specific deletion of a floxed Mgat1 gene using a zona pellucida protein 3 (ZP3)Cre transgene produce fewer pups primarily due to a reduction in ovulation rate. Here, we show that the ovulation rate of mutant females is decreased due to aberrant development of preovulatory follicles. After a superovulatory regime of 48 h pregnant mare's serum (PMSG) and 9 h human
chorionic gonadotropin
(hCG), mutant ovaries weighed less and contained approximately 60% fewer preovulatory follicles and more atretic and abnormal follicles than controls. Unlike controls, a proportion of mutant follicles underwent premature luteinization. In addition, mutant preovulatory oocytes exhibited gross abnormalities with approximately 36% being blebbed or zona-free. While 97% of wild-type oocytes had a perivitelline space at the preovulatory stage, approximately 54% of mutant oocytes did not. The cumulus mass surrounding mutant oocytes was also smaller with a decreased number of proliferating cells compared with controls, although hyaluronan around mutant oocytes was similar to controls. In addition, cumulus cells surrounding mutant eggs were resistant to removal by either
hyaluronidase
or incubation with capacitated sperm. Therefore, the absence of complex and hybrid N-glycans on oocyte glycoproteins leads to abnormal folliculogenesis resulting in a decreased ovulation rate.
...
PMID:Oocyte-specific deletion of complex and hybrid N-glycans leads to defects in preovulatory follicle and cumulus mass development. 1902 23